优化和稳定性评估的儿科螺旋诺拉克口服悬浮剂:配方开发和分析验证验证
Roxanne Desquines1, Zoubeir Ramjaun1, Acil Jaafar2
1University Hospital Centre Toulouse, Department of Pharmacy, France.
概括
这项研究为儿科患者开发了一种稳定的口服螺旋乳悬浮剂,改善了对先天性心脏病等疾病的药物获取. 这种新配方确保了对需要螺旋龙治疗的儿童的安全性和有效性.
科学领域:
- 制药科学 制药科学
- 儿科药理学 儿科药理学
- 制定 发展 制定 发展
背景情况:
- 儿科患者面临着药物可用性方面的挑战,特别是对于先天性心脏病等需要螺旋龙的疾病.
- 现有的spironolactone配方可能不适合小儿治疗,需要专门的剂量形式.
研究的目的:
- 为了优化口服悬浮spironolactone的药物配方用于儿科使用.
- 评估开发的儿科螺旋诺拉克口服悬浮剂的稳定性和质量.
主要方法:
- 在InOrpha®中开发一种使用0.2%的香的口服悬浮配方.
- 一种分析方法的验证,以准确量化螺旋乳.
- 强制降解研究,以确保该方法的稳定性指示性质.
- 在各种储存条件下进行全面的稳定性评估 (化学,物理,微生物学).
主要成果:
- 与以前的版本相比,优化的配方表现出增强的稳定性和减少沉积.
- 分析方法的准确性和精确性得到了验证.
- 口服悬浮剂在打开前的135天和打开后的37天内,在化学,物理和微生物学上均稳定.
- 强制降解研究证实了该方法能够检测螺旋乳降解产物.
结论:
- 开发的口服螺旋诺拉克悬浮剂是儿童患者的稳定和可行的选择.
- 这种配方解决了对儿童,特别是患有先天性心脏病的儿童进行适当的螺旋乳输送的需要.
- 建议对药理动力学 (生物可用性,药理动力学) 进行进一步的研究,以确认在儿童群体中的疗效.
相关概念视频
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
269
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
269
Factors Influencing Drug Absorption: Pharmaceutical Parameters
197
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
197
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
406
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
406
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
517
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
517
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.4K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.4K
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.0K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.0K


